1-4 of 4
James M. D'Rozario, MBBS FRACP FRCPA
Close
Sort by
Journal Articles

Pomalidomide Alone or in Combination with Low Dose Dexamethasone As Maintenance Following Induction with Pomalidomide and Low Dose Dexamethasone in Relapsed and Refractory Myeloma (ALLG MM14)

Anna Kalff, MBBS, Nola Kennedy, John Reynolds, PhD, Hang Quach, MDFRACP,FRCPA,MBBS, Phoebe Joy Ho, MBBS, Noemi Horvath, MBBS FRACP FRCPA, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, James M. D'Rozario, MBBS, FRACP, FRCPA, Kerry Taylor, FRACP,FRCPA,MBBS, Jane Estell, FRACP, Andrew Spencer, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 1986.
https://doi.org/10.1182/blood-2018-99-118231
Published: 2018
Journal Articles

Randomized Phase III Study (ADMYRE) of Plitidepsin in Combination with Dexamethasone Vs. Dexamethasone Alone in Patients with Relapsed/Refractory Multiple Myeloma

Ivan Spicka, MDPhD, Enrique M. Ocio, MDPhD, Heather E. Oakervee, MBBS MD, Richard Greil, MD, Raymond H. Banh, MD, Laurence Catley, MD, Shang-Yi Huang, MD, PhD, James M. D'Rozario, MBBS FRACP FRCPA, Meletios A. Dimopoulos, José Rodríguez, MDPhD, Sara Martinez, MD, Sonia Extremera, BsC, Vicente Alfaro, MsC PhD, Angelo Michele Carella, MD, Nathalie Meuleman, MDPhD, Roman Hájek, MD, Argiris Symeonidis, MD PhD, Chang-Ki Min, MD, Paul Cannell, MD, Heinz Ludwig, MD, Pieter Sonneveld, MDPhD, Maria V. Mateos, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1886.
https://doi.org/10.1182/blood.V130.Suppl_1.1886.1886
Published: 2017
Journal Articles

Venetoclax Plus Rituximab Is Superior to Bendamustine Plus Rituximab in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia - Results from Pre-Planned Interim Analysis of the Randomized Phase 3 Murano Study

John F Seymour, MBBS, PhD, Thomas J. Kipps, MD, Barbara F. Eichhorst, MD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, James M. D'Rozario, MBBS FRACP FRCPA, Sarit Assouline, MD, Carolyn Jane Owen, MD FRCPC, John Gerecitano, MD PhD, Tadeusz Robak, MD PhD, Javier De la Serna, MD, Ulrich Jaeger, MD, Guillaume Cartron, MD PhD, Marco Montillo, MD, Rod Humerickhouse, MD PhD, Elizabeth Punnoose, PhD, Yan Li, PhD, Michelle Boyer, PhD, Kathryn Humphrey, BSc, Mehrdad Mobasher, MD, MPH, Arnon P. Kater, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): LBA-2.
https://doi.org/10.1182/blood.V130.Suppl_1.LBA-2.LBA-2
Published: 2017
Journal Articles

Successful Treatment of Alemtuzumab Induced Immune Thrombocytopenia with a Thrombopoietin Receptor Agonist

Fathima Mohiyaddin Ayyalil, MBBS, James Slade, BN, GCCaN, MNNP, Daniel Wang, MBBS, James M. D'Rozario, MBBS FRACP FRCPA, Stephen Reddel, MBBS, FRACP, PhD, Philip Young-Ill Choi, BA, BSc, MBBS, PhD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 2326.
https://doi.org/10.1182/blood.V130.Suppl_1.2326.2326
Published: 2017